Literature DB >> 11911585

Effects of pentoxifylline on pulmonary function and results of cytologic examination of bronchoalveolar lavage fluid in horses with recurrent airway obstruction.

Renaud Léguillette1, Cyril Désévaux, Jean-Pierre Lavoie.   

Abstract

OBJECTIVES: To determine the effects of pentoxifylline (PTX) administration on lung function and results of cytologic examination of bronchoalveolar lavage fluid in horses affected by recurrent airway obstruction (RAO). ANIMALS: 10 RAO-affected horses. PROCEDURES: 6 horses were orally administered PTX (16 g) mixed with corn syrup, and 4 horses were administered corn syrup alone, twice daily for 14 days. Pulmonary function was evaluated before administration (day 0) and on days 8 and 15. Bronchoalveolar lavage (BAL) was performed on days 0 and 15. Reversibility of airway obstruction was assessed by measuring pulmonary function before and after administration of atropine (0.02 mg/kg, IV). Serum concentration of PTX was measured in 4 horses 30 minutes and 2 and 4 hours after administration of PTX on days 1, 2, 3, 7 and 14.
RESULTS: Administration of PTX to BAO-affected horses resulted in a decrease in elastance value on day 8 and on elastance and resistance (RL) values on days 8 and 15. Results for cytologic examination of BAL fluid obtained on day 15 did not differ significantly, compared with values for day 0. Values of RL decreased in all horses following administration of atropine. When mixed in corn syrup and administered orally, PTX was poorly absorbed in horses, and there was noticeable variation in serum PTX concentrations over time and among horses. CONCLUSIONS AND CLINICAL RELEVANCE: Based on these results, it can be concluded that administration of PTX at high doses improved respiratory function of RAO-affected horses maintained in an unfavorable environment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911585     DOI: 10.2460/ajvr.2002.63.459

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

1.  Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Jessica A Cervelli; Rama Malaviya; LeRoy Hall; Christopher B Massa; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2014-06-02       Impact factor: 3.362

2.  Inflammatory Airway Disease of Horses--Revised Consensus Statement.

Authors:  L L Couëtil; J M Cardwell; V Gerber; J-P Lavoie; R Léguillette; E A Richard
Journal:  J Vet Intern Med       Date:  2016-01-24       Impact factor: 3.333

Review 3.  Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?

Authors:  Ann Kristin Barton; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2016-12-07       Impact factor: 4.711

4.  Effect of Dexamethasone and Fluticasone on Airway Hyperresponsiveness in Horses With Inflammatory Airway Disease.

Authors:  R Léguillette; T Tohver; S L Bond; J A Nicol; K J McDonald
Journal:  J Vet Intern Med       Date:  2017-05-31       Impact factor: 3.333

Review 5.  Equine asthma: Integrative biologic relevance of a recently proposed nomenclature.

Authors:  Stephanie Bond; Renaud Léguillette; Eric A Richard; Laurent Couetil; Jean-Pierre Lavoie; James G Martin; R Scott Pirie
Journal:  J Vet Intern Med       Date:  2018-10-07       Impact factor: 3.333

6.  Pharmacokinetics and ex vivo anti-inflammatory effects of oral misoprostol in horses.

Authors:  E M Martin; J M Schirmer; S L Jones; J L Davis
Journal:  Equine Vet J       Date:  2018-10-23       Impact factor: 2.888

7.  Efficacy of dexamethasone, salbutamol, and reduced respirable particulate concentration on aerobic capacity in horses with smoke-induced mild asthma.

Authors:  Stephanie L Bond; Persephone Greco-Otto; Jacqueline MacLeod; Angelica Galezowski; Warwick Bayly; Renaud Léguillette
Journal:  J Vet Intern Med       Date:  2020-01-18       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.